K
v
ire
.com
your senior peer reviewer
←
Back
Night
Docs
Editor
Drafts
Library
Search
…
Author
Ludwig Kappos
also known as KAPPOS, L, Kappos, L, Kappos, L.
University of Basel · University Hospital of Basel · Hospital Base · Université Claude Bernard Lyon 1
About this author
Works
1,335
Cited by
102,670
h-index
138
i10
626
ORCID ↗
Top papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell, et al.
·
2011
·
Annals of Neurology
↗ 9,788
OA
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson, Brenda Banwell, Frederik Barkhof, et al.
·
2017
·
The Lancet Neurology
↗ 7,828
OA
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Chris H. Polman, Stephen C. Reingold, Gilles Edan, et al.
·
2005
·
Annals of Neurology
↗ 4,983
OA
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen, et al.
·
2014
·
Neurology
↗ 3,082
OA
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor, et al.
·
2010
·
New England Journal of Medicine
↗ 2,615
OA
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen, Frederik Barkhof, Gıancarlo Comı, et al.
·
2010
·
New England Journal of Medicine
↗ 2,189
OA
Neurofilaments as biomarkers in neurological disorders
Michael Khalil, Charlotte E. Teunissen, Markus Otto, et al.
·
2018
·
Nature Reviews Neurology
↗ 1,930
OA
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L. Hauser, Amit Bar‐Or, Gıancarlo Comı, et al.
·
2016
·
New England Journal of Medicine
↗ 1,928
OA
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos, et al.
·
2016
·
New England Journal of Medicine
↗ 1,831
OA
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold, Ludwig Kappos, Douglas L. Arnold, et al.
·
2012
·
New England Journal of Medicine
↗ 1,698
OA
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Giulio Disanto, Christian Barro, Pascal Benkert, et al.
·
2017
·
Annals of Neurology
↗ 1,132
OA
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Ludwig Kappos, Jack P. Antel, Giancarlo Comi, et al.
·
2006
·
New England Journal of Medicine
↗ 1,054
OA
Books
Immunsuppressive Therapie der multiplen Sklerose mit Cyclosporin A und Azathioprin
1990
·
Springer Berlin Heidelberg
Multiple sclerosis
2000
·
Informa Healthcare
Physiotherapie bei Multipler Sklerose. Funktionelles, bewegungsanalytisches Behandlungskonzept.
1998
·
Thieme, Stuttgart
Multiple sclerosis
2001
·
Martin Dunitz